Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Be cautious

$Verona Pharma (VRNA.US)$ shorters will try to push it down. this is a long term hold being a blockbuster drug, with a 2 billion potential further down the road. revenue forecast for this year 40 million. hopefully conference call is giving the price a boost. if a big pharma might do a take over, it goes sky rocketing. whatever it is, don’t sell cheap. Disclaimer: not financial advice.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
+0
Translate
Report
8931 Views
Comment
Sign in to post a comment